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Abstract 
Transplacental infection plays a critical role in the reproductive failure induced by porcine reproductive and respira‑
tory syndrome virus (PRRSV), yet exposure of sows and gilts to classical PRRSV generally leads to reproductive failure 
after 85 days of gestation. We report, for the first time, that the susceptibility of fetuses to highly pathogenic PRRSV 
(HP‑PRRSV) is similar at 60 days and 90 days of gestation. This difference from classical PRRSV may contribute to its 
high pathogenicity. A field study of the HP‑PRRSV vaccine in pregnant sows at mid‑gestation should be considered.
© 2015 Wang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction, methods and results
Porcine reproductive and respiratory syndrome (PRRS), 
caused by porcine reproductive and respiratory syn-
drome virus (PRRSV), is one of the most severe swine 
diseases leading to great economic losses worldwide. 
PRRSV is an enveloped, single-stranded positive-sense 
RNA virus, belonging to the family Arteriviridae in the 
order Nidovirales. The genome of PRRSV is approxi-
mately 15 kb in length and contains at least 10 open read-
ing frames encoding 8 structural proteins and 13–16 
nonstructural proteins (nsps) [1, 2]. The nsp2 gene is 
the most highly variable region of the genome and con-
tributes to the virulence and genotype of PRRSV [3, 4]. 
In 2006, a highly pathogenic PRRSV (HP-PRRSV) was 
identified in China, causing great concern in the global 
swine industry [5]. HP-PRRSV is genetically character-
ized by a unique discontinuous 30-amino-acid deletion 
in nsp2 gene [6, 7]. HP-PRRS caused by HP-PRRSV is 
characterized by high fever (41–42 °C), high illness rates 
(50–100%), high death rates (20–100%), and high abor-
tion rates (40%), resulting in devastating economic losses 
[5–7]. To date, HP-PRRSV has been found in North, East, 
and South Asia [8–10].
Reproductive failure is one of the prominent clini-
cal manifestations of PRRS, and pregnant sows exposed 
to PRRSV give birth to dead, stillborn, or mummified 
fetuses. Persistent uterine infection contributes to repro-
ductive failure in sows. The ability of the virus to cross 
the placental barrier is critical for fetal infection because 
pig embryos are not susceptible to PRRSV prior to 
implantation [11, 12]. The ability to cross the placenta is 
strain-dependent; for example, the Spanish PRRSV strain 
5710 has been shown to infect 20-day-old embryos when 
gilts were exposed at the onset of gestation [13]. In con-
trast, sows infected with a Danish isolate of PRRSV had 
the highest transplacental transmission rate at day 85 of 
gestation, with less transmission at day 72 of gestation, 
and none on day 45 of gestation [14]. Furthermore, it 
has been reported that a Danish vaccine strain (19407B) 
of PRRSV caused congenital infection, fetal death, and 
pre-weaning piglet mortality after it was administered 
intranasally to sows [15]. Another two European-type 
modified-live-virus vaccine strains, VP-046 Bis and All-
183, can also cross the placenta and result in congenital 
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infection of piglets at birth [16]. The typical type II isolate 
ATCC VR-2332 causes reproductive failure in 93-day-
pregnant sows but does not induce reproductive fail-
ure when administered at mid-term gestation [17, 18]. 
Although the capacity for transplacental infection var-
ies, classical PRRSV cause transplacental infection with 
consequent abortion predominantly when the sows are 
exposed during late gestation. However, it is unclear 
whether the newly emerged HP-PRRSV has an enhanced 
ability to cross the placenta.
To investigate the ability of HP-PRRSV to cross the pla-
centa, 30 cross-bred Landrace × Large White gilts were 
obtained from a PRRSV-free herd and tested using both 
RT-PCR and enzyme-linked immunosorbent assay to 
confirm that they were PRRSV-negative. The gilts were 
artificially inseminated and randomly allocated to one 
of two control groups (n = 6 sows/group) or one of two 
treatment groups (n  =  9 sows/group). Inoculums from 
uninfected cell cultures were used to sham-infect the two 
control groups at 60 and 90  days of gestation, respec-
tively. The two treatment groups were inoculated intra-
nasally at day 60 and 90 of gestation, respectively, with 
106 median tissue culture infective doses (TCID50) of HP-
PRRSV strain TA-12 collected from HP-PRRSV infected 
Marc-145 cells (GenBank HQ417620). Clinical signs of 
PRRSV infection, including reduced appetite, low energy, 
and high fever, were observed from 3 days post infection 
(dpi). Two sows in the day 90 infected group aborted at 
13 dpi and 17 dpi, corresponding to gestation days 103 
and 107, respectively. All the sows in the sham-inocula-
tion control groups remained clinically normal.
A quantitative RT-PCR (qRT-PCR) targeting the HP-
PRRSV conserved nucleocapsid (N) protein gene was 
developed to detect HP-PRRSV using specific primers 
(forward primer 5′-AGATCATCGCCCAACAAAAC-3′; 
reverse primer 5′-GACACAATTGCCGCTCACTA-3′). 
HP-PRRSV was detected in the sera from 4 to 14 dpi with 
qRT-PCR, with the peak titer at 7 dpi. No PRRSV mRNA 
were detected in the sera of the sham-infected sows 
throughout the experiment (Figure 1).
At 7, 14, and 21 dpi, three sows in the HP-PRRSV-
infected groups and two sows in the sham-infected 
groups were sacrificed by barbiturate overdose, which is 
a euthanasia method approved by the Animal Care and 
Use Committee of Shandong Agricultural University. 
Tissue and blood samples were collected from the sows 
and fetuses. At necropsy, similar gross lesions were found 
in the day 60 and 90 infected sows, including interstitial 
pneumonia and lymph node edema. Sporadic hemor-
rhagic spots were also found in the fetal organs, including 
the liver, lymph nodes, and hearts of fetuses in both day 
60 and 90 infected groups. In contrast, no gross lesions 
were found in the sham-infected sows or their fetuses. 
HP-PRRSV RNA was detected in the amnion and in the 
umbilical cords of infected sows. At 7 dpi, significantly 
higher levels of virus were detected in the amnion in 
sows infected at day 90 of gestation than in sows infected 
at day 60 of gestation (Figure 2). However, more copies of 
HP-PRRSV were detected in both the amnion and umbil-
ical cords in day 60 infected sows than in day 90 infected 
sows at 14 dpi. These results indicate that the intranasal 
inoculation with HP-PRRSV led to successful infection of 
the sows.
Sialoadhesin (Sn) and CD163 are PRRSV cellu-
lar receptors [19]. PRRSV has a restricted tropism for 
Sn+CD163+ macrophages [20, 21] and the presence of 
Sn+CD163+ macrophages in the placenta is essential 
for the transmission of the virus from mother to fetus. 
Thus, we evaluated placental relative mRNA expression 
levels of Sn and CD163 (compared with mRNA expres-
sion levels of beta actin) at 7 dpi (Figure  3). Two-way 
analysis of variance (ANOVA) performed using Graph-
Pad Prism 5 revealed significant increases in the placen-
tal expression of Sn mRNA after HP-PRRSV infection at 
both day 60 and 90 of gestation. Placental expression of 
CD163 mRNA increased only in sows infected at day 90 
of gestation.
To exclude the possibility that fetal infection was influ-
enced by differences in sow susceptibility to the virus, 
the viral loads in the spleens, brains, lungs, and uteri of 
infected and sham-infected sows at 7 dpi were deter-
mined using qRT-PCR. There were no differences in the 
viral loads among any of the organs examined (data not 
shown), which suggests that we successfully developed 
an animal model suitable for the study of transplacental 
infection by HP-PRRSV.
Figure 1 Analysis of viremia in serum samples. Viral load, meas‑
ured as the copy number of highly pathogenic porcine reproductive 
and respiratory syndrome virus (HP‑PRRSV), in serum samples from 
the day 60 and 90 infected groups at 0, 4, 7, 14, and 21 days post‑
infection (dpi). All samples were analyzed in triplicate.
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Conventional RT-PCR targeting the nsp2 gene was 
employed to assess infection status. Detection of the 
680-bp nsp2 gene is more specific than detection of the 
N gene because it is less abundantly expressed. The fetal 
infection status was evaluated by detecting the nsp2 
gene in fetal spleens. Total splenic RNA were extracted 
with TRIzol Reagent (Life Technologies, Gaithersburg, 
MD, USA) and tested with a one-step RNA PCR kit, 
using primers specific for the nsp2 gene (forward primer 
5′-AGACCAGATGGAGGAGGATCTGC-3′; reverse 
primer 5′-AGTCGATGATGGCTTGAGCTGAG-3′). 
In the 60-day infection group, 42.9 (12/28) and 46.7% 
(14/30) of the fetuses examined were infected at 7 and 
14 dpi, respectively. In the day 90 infected group, 41.7 
Figure 2 HP-PRRSV loads in the organs at 7, 14, and 21 dpi. All 
values are expressed as mean ± standard deviation of the mean (SD). 
Statistical analyses were performed using GraphPad Prism 5. Differ‑
ences were considered significant at P < 0.05. * P < 0.05.
Figure 3 Relative placental CD163 and Sn mRNA expression 
levels. CD163 (A) and Sn (B) mRNA expression levels in day 60 and 
90 infected and sham‑infected sows at 7 dpi. All values are expressed 
as mean ± standard deviation of the mean (SD). Statistical analyses 
were performed using GraphPad Prism 5. Differences were consid‑
ered significant at P < 0.05. * P < 0.05.
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(10/24) and 60% (12/20) of fetuses were positive for HP-
PRRSV at 7 and 14 dpi, respectively. In the litters that 
were aborted at 13 and 17 dpi, the fetal infection rates 
were 63.6% (7 of 11 fetuses) and 50% (5 of 10 fetuses), 
respectively. Sows infected with HP-PRRSV at 60  days 
of gestation had a similar proportion of infected fetuses: 
16 of 25 (64%) fetuses were infected at 21 dpi compared 
with 14 of 24 (58%) fetuses from sows infected at 90 days 
of gestation. These results demonstrate that fetuses from 
the 60-day and 90-day infected groups did not differ in 
their fetal infection rates.
Another way to evaluate the capacity of HP-PPRSV 
for placental infection is to determine the viral load in 
the fetal organs. The organs (spleen, thymus, lung, liver, 
heart, and kidney) of all fetuses were tested for the virus 
with qRT–PCR and their viral loads were compared 
among groups (Figure  2). The spleens of fetuses in the 
day 60 infected group contained significantly more virus 
than those from fetuses in the day 90 infected group at 
7 and 21 dpi. At 14 dpi, the thymuses of fetuses in the 
day 60 infected group contained significantly more virus 
than those from fetuses in the day 90 infected group. 
Significantly more virus was also found in the hearts of 
the fetuses from the day 90 infected group at 7 dpi rela-
tive to the day 60 infected group, and in the kidneys of 
the fetuses from the day 60 infected group at 14 dpi rela-
tive to the day 90 infected group. The viral loads were sig-
nificantly higher in the livers of the day 90 infected group 
fetuses than in the day 60 infected group at 7 dpi, but 
much lower at 21 dpi. The viral load in the fetal lungs did 
not differ in between groups at any time point. The sta-
tistical significance of inter-group differences were deter-
mined by two-way ANOVA analysis performed using 
GraphPad Prism 5.
To confirm fetal infection, the spleens from the fetuses 
with high titers of HP-PRRSV were sectioned and viral 
antigen was detected with immunohistochemistry using 
the monoclonal antibody 6D10 (IgG1) directed against 
the PRRSV N protein [22]. Uninfected material stained 
with the monoclonal antibody 6D10 and infected mate-
rial stained an anti-green fluorescent protein, a mono-
clonal antibody with the same isotype was used as the 
negative control. PRRSV-positive cells in the spleens of 
the infected fetuses appeared brown due to the presence 
Figure 4 Immunohistochemical detection of HP-PRRSV in the fetal spleen at 7 dpi. (A, C) Negative control splenic tissue, in which mouse 
IgG was substituted for the primary antibody; (B) spleenic tissue from the day 60 infected group; (D) spleenic tissue from the day 90 infected group. 
All images are shown at ×40 magnification.
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of diaminobenzidine (Figure  4), but no PRRSV-positive 
cells were seen in the control fetuses.
Discussion
The ability of PRRSV to cross the placenta and infect 
fetuses varies with strain. Successful transplacental 
infection depends on the ability of the virus to cross the 
placenta and replicate within the fetus, evading both 
maternal and fetal immune responses. Our results show 
that HP-PRRSV transplacentally infected fetuses in both 
the day 60 and 90 infected groups. Evaluation of fetal 
infection rates and viral loads in fetal organs revealed that 
HP-PRRSV is equally capable of crossing the placenta at 
day 60 and 90 of gestation.
Fetal infection rates at each time point were not signifi-
cantly different and the viral loads were similar between 
the day 60 and 90 infected groups. These results sup-
port the hypothesis that fetuses are similarly susceptible 
to infection with HP-PRRSV at day 60 and 90 of gesta-
tion. Although in this study we did not simultaneously 
evaluate transplacental infection with classical PRRSV, 
previous studies have shown that the number of fetuses 
infected with classical PRRSV during mid-gestation is 
lower than the number infected during late gestation [14, 
17, 18]; this is different from the result we obtained with 
HP-PRRSV.
In this study, much higher levels of virus were detected 
at 7 dpi in the placentas of sows infected at day 90 of ges-
tation than in those from sows infected at day 60 of gesta-
tion; this is likely due to the lower expression of the Sn on 
placental macrophages at day 60 of gestation [21]. How-
ever, HP-PRRSV infection up-regulated the expression 
of Sn mRNA; Sn plays a vital role in receptor-mediated 
endocytosis of PRRSV. Low Sn expression may explain 
why the HP-PRRSV load was high in the day 90 placenta 
while the proportion of fetuses infected was similar to 
that seen in sows exposed on day 60. Of course, unknown 
interactions between HP-PRRSV and the host immune 
response may also explain these findings.
In the field, HP-PRRSV infection is complicated by 
concomitant infection by other pathogens, which can 
result in severe morbidity and mortality. In the pre-
sent study, a lower abortion rate (10%) was observed in 
the day 90 infected sows. The reason for this lower rate 
may be their reduced opportunity for exposure to other 
pathogens under laboratory conditions, which would 
have improved the pregnant sows’ ability to fight the 
HP-PRRSV infection. In this single-pathogen model, we 
have provided experimental evidence that HP-PRRSV is 
equally capable of crossing the placenta and causing fetal 
infection in sows at day 60 and 90 of gestation. The sever-
ity of the disturbance to reproductive hormone concen-
trations caused by HP-PRRSV during late gestation may 
explain why only sows in late gestation aborted during 
this study [22].
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